Cargando…

A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is a major threat to people's health. PRDM1 is a transcription factor with multiple functions, and its functions have been validated in a variety of tumors; however, there are few studies reported on PRDM1 in PAAD. Using the GEPIA2 database, this research found...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Bo, Zhang, Jie, Zhu, Hongda, Wu, Shugeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123419/
https://www.ncbi.nlm.nih.gov/pubmed/35607327
http://dx.doi.org/10.1155/2022/1934381
_version_ 1784711550929469440
author Zhou, Bo
Zhang, Jie
Zhu, Hongda
Wu, Shugeng
author_facet Zhou, Bo
Zhang, Jie
Zhu, Hongda
Wu, Shugeng
author_sort Zhou, Bo
collection PubMed
description Pancreatic adenocarcinoma (PAAD) is a major threat to people's health. PRDM1 is a transcription factor with multiple functions, and its functions have been validated in a variety of tumors; however, there are few studies reported on PRDM1 in PAAD. Using the GEPIA2 database, this research found that PRDM1 expression in PAAD was significantly higher than that in normal pancreatic tissue. The Kaplan-Meier Plotter database showed that high expression of PRDM1 in PAAD has a poor prognosis, suggesting that PRDM1 may be a potential prognostic marker in PAAD. The cBioPortal database shows that the expression of PRDM1 in PAAD is significantly correlated with its methylation degree. Further analysis on the coexpressed genes of PRDM1 in PAAD was performed by using LinkedOmics database to explore potential mechanisms. Based on gene enrichment analysis, PRDM1 was implicated in many pathways involved in tumor progression. In the construction of a PPI network of PRDM1 and its coexpressed gene protein via the STRING database, we found that PRDM1 may be involved in the pathogenesis and development of PAAD. TIMER database suggested that a high level of PRDM1 has a significant positive correlation with macrophages, neutrophils, and DCs. Potential methylation sites of PRDM1 were found through DNMIVD database, and MethSurv database explored eight sites which were significantly related with the prognosis of PAAD. In conclusion, PRDM1 may work as a prognostic marker or even provide a potential therapeutic strategy in PAAD.
format Online
Article
Text
id pubmed-9123419
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91234192022-05-22 A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma Zhou, Bo Zhang, Jie Zhu, Hongda Wu, Shugeng J Oncol Research Article Pancreatic adenocarcinoma (PAAD) is a major threat to people's health. PRDM1 is a transcription factor with multiple functions, and its functions have been validated in a variety of tumors; however, there are few studies reported on PRDM1 in PAAD. Using the GEPIA2 database, this research found that PRDM1 expression in PAAD was significantly higher than that in normal pancreatic tissue. The Kaplan-Meier Plotter database showed that high expression of PRDM1 in PAAD has a poor prognosis, suggesting that PRDM1 may be a potential prognostic marker in PAAD. The cBioPortal database shows that the expression of PRDM1 in PAAD is significantly correlated with its methylation degree. Further analysis on the coexpressed genes of PRDM1 in PAAD was performed by using LinkedOmics database to explore potential mechanisms. Based on gene enrichment analysis, PRDM1 was implicated in many pathways involved in tumor progression. In the construction of a PPI network of PRDM1 and its coexpressed gene protein via the STRING database, we found that PRDM1 may be involved in the pathogenesis and development of PAAD. TIMER database suggested that a high level of PRDM1 has a significant positive correlation with macrophages, neutrophils, and DCs. Potential methylation sites of PRDM1 were found through DNMIVD database, and MethSurv database explored eight sites which were significantly related with the prognosis of PAAD. In conclusion, PRDM1 may work as a prognostic marker or even provide a potential therapeutic strategy in PAAD. Hindawi 2022-05-13 /pmc/articles/PMC9123419/ /pubmed/35607327 http://dx.doi.org/10.1155/2022/1934381 Text en Copyright © 2022 Bo Zhou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhou, Bo
Zhang, Jie
Zhu, Hongda
Wu, Shugeng
A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
title A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
title_full A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
title_fullStr A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
title_full_unstemmed A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
title_short A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma
title_sort potential prognostic marker prdm1 in pancreatic adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123419/
https://www.ncbi.nlm.nih.gov/pubmed/35607327
http://dx.doi.org/10.1155/2022/1934381
work_keys_str_mv AT zhoubo apotentialprognosticmarkerprdm1inpancreaticadenocarcinoma
AT zhangjie apotentialprognosticmarkerprdm1inpancreaticadenocarcinoma
AT zhuhongda apotentialprognosticmarkerprdm1inpancreaticadenocarcinoma
AT wushugeng apotentialprognosticmarkerprdm1inpancreaticadenocarcinoma
AT zhoubo potentialprognosticmarkerprdm1inpancreaticadenocarcinoma
AT zhangjie potentialprognosticmarkerprdm1inpancreaticadenocarcinoma
AT zhuhongda potentialprognosticmarkerprdm1inpancreaticadenocarcinoma
AT wushugeng potentialprognosticmarkerprdm1inpancreaticadenocarcinoma